Crossmark

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study

Crossref DOI link: https://doi.org/10.1186/s12885-018-5248-y

Published Online: 2019-01-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Egli-Gany, Dianne https://orcid.org/0000-0002-4725-0475
Spaar Zographos, Anne

Diebold, Joachim

Masserey Spicher, Virginie https://orcid.org/0000-0003-2839-7073
Frey Tirri, Brigitte

Heusser, Rolf

Dillner, Joakim https://orcid.org/0000-0001-8588-6506
Petignat, Patrick https://orcid.org/0000-0002-6835-533X
Sahli, Roland https://orcid.org/0000-0001-7513-1142
Low, Nicola https://orcid.org/0000-0003-4817-8986
Funding

Funding for this research was provided by:

Swiss Cancer Research (KFS-3264-08-2013)

Federal Office of Public Health Switzerland (15.000704)
License Information

Text and Data Mining valid from 2019-01-30
More Information

Article History

Received: 10 August 2018

Accepted: 26 December 2018

First Online: 30 January 2019

Consent for publication

: Not applicable.

: This study was reviewed and approved by the ethics committees in all participating Swiss cantons (Ethics Committee Bern 194–24, Ethics Committee Northwest/Central Switzerland 2014–280, Ethics Committee Geneva 14–176, Ethics Committee Zurich 2014–0363, Ethics Committee Ticino 2839). Written informed consent was obtained from participants.

: Joakim Dillner reports previously having received funding from Merck Sharp & Dohme, a vaccine manufacturer. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below